Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-20 Sale | 2024-02-21 9:41 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 24,888 | $14.11 | $351,289 | 395,394 (Direct) | View |
| 2024-02-14 Sale | 2024-02-16 4:20 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 58,356 | $15.01 | $875,883 | 181,676 (Direct) | View |
| 2024-02-01 Sale | 2024-02-05 5:55 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $16.22 | $162,198 | 117,532 (Direct) | View |
| 2023-12-27 Sale | 2023-12-28 4:28 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 30,000 | $12.02 | $360,453 | 127,532 (Direct) | View |
| 2023-11-20 Sale | 2023-11-21 4:30 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 14,807 | $8.2293 | $121,851 | 271,138 (Direct) | View |
| 2023-08-18 Sale | 2023-08-21 8:05 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 14,876 | $10.73 | $159,602 | 273,112 (Direct) | View |
| 2023-05-18 Sale | 2023-05-19 9:17 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 5,627 | $10.14 | $57,083 | 350,489 (Direct) | View |
| 2023-02-17 Sale | 2023-02-23 5:40 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 6,700 | $7.66 | $51,322 | 196,392 (Direct) | View |
| 2022-11-18 Sale | 2022-11-21 4:17 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 1,785 | $5.44 | $9,710 | 196,148 (Direct) | View |
| 2022-09-02 Sale | 2022-09-07 4:50 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 1,320 | $17.01 | $22,458 | 110,858 (Direct) | View |
| 2022-08-17 Sale | 2022-08-19 4:58 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 1,797 | $14.96 | $26,890 | 203,261 (Direct) | View |
| 2022-03-09 Sale | 2022-03-11 4:56 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $17.07 | $170,693 | 114,670 (Direct) | View |
| 2021-10-01 Sale | 2021-10-04 4:57 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $17.18 | $171,841 | 124,670 (Direct) | View |
| 2021-07-01 Sale | 2021-07-02 5:35 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $24.15 | $241,477 | 134,670 (Direct) | View |
| 2021-06-17 Sale | 2021-06-22 5:15 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 1,067 | $30.04 | $32,051 | 144,670 (Direct) | View |
| 2021-06-09 Sale | 2021-06-11 7:29 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 8,933 | $30.05 | $268,480 | 145,737 (Direct) | View |
| 2021-04-01 Sale | 2021-04-05 6:38 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $27.44 | $274,436 | 159,420 (Direct) | View |
| 2021-02-23 Sale | 2021-02-25 8:20 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $33.55 | $335,538 | 169,420 (Direct) | View |
| 2021-01-04 Sale | 2021-01-06 5:33 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $18.19 | $181,904 | 179,420 (Direct) | View |
| 2020-10-20 Sale | 2020-10-22 5:33 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 38,539 | $17.98 | $693,025 | 195,420 (Direct) | View |
| 2020-10-16 Sale | 2020-10-20 2:08 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 1,261 | $17.01 | $21,444 | 233,959 (Direct) | View |
| 2020-02-05 Sale | 2020-02-07 5:14 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 200 | $17.05 | $3,410 | 238,220 (Direct) | View |
| 2019-12-20 Sale | 2019-12-26 5:30 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 2,300 | $17.02 | $39,150 | 238,420 (Direct) | View |
| 2019-12-12 Sale | 2019-12-16 7:32 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 7,700 | $17.06 | $131,352 | 240,720 (Direct) | View |
| 2019-07-15 Sale | 2019-07-17 6:52 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $17.04 | $170,407 | 248,510 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-17 Exercise | 2024-02-21 9:41 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 108,830 | $0 | 395,394 (Direct) | View |
| 2024-02-11 Option Award | 2024-02-13 09:08 am | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 205,833 | $0 | 323,365 (Direct) | View |
| 2023-11-17 Exercise | 2023-11-21 4:30 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 67,166 | $0 | 271,138 (Direct) | View |
| 2023-10-30 Gift | 2023-11-01 4:12 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 8,000 | $0 | 138,756 (Direct) | View |
| 2023-08-17 Exercise | 2023-08-21 8:05 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 67,164 | $0 | 273,112 (Direct) | View |
| 2023-02-17 Exercise(A) | 2023-05-22 9:36 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 6,944 | $0 | 76,390 (Direct) | View |
| 2023-05-17 Exercise | 2023-05-19 9:17 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 25,500 | $0 | 350,489 (Direct) | View |
| 2023-01-11 Option Award | 2023-05-19 9:17 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 83,334 | $0 | 350,489 (Direct) | View |
| 2023-02-17 Exercise | 2023-02-23 5:40 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 25,498 | $0 | 196,392 (Direct) | View |
| 2022-11-17 Exercise | 2022-11-21 4:17 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 5,805 | $0 | 196,148 (Direct) | View |
| 2022-07-02 Gift | 2022-09-07 4:50 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 6,500 | $0 | 110,858 (Direct) | View |
| 2022-08-17 Exercise | 2022-08-19 4:58 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 5,805 | $0 | 203,261 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:55 pm | N/A 2032-05-16 | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 154,800 | $0 | 154,800 (Direct) | View |
| 2021-04-29 Gift | 2021-05-28 5:23 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 4,750 | $0 | 354,670 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:23 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 200,000 | $0 | 354,670 (Direct) | View |
| 2021-02-07 Option Award | 2021-02-08 9:32 pm | N/A 2029-05-15 | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 115,000 | $0 | 115,000 (Direct) | View |
| 2020-10-29 Gift | 2021-01-06 5:33 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 6,000 | $0 | 179,420 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 5:58 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 140,000 | $0 | 140,000 (Direct) | View |
| 2020-04-29 Gift | 2020-10-20 2:08 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 3,000 | $0 | 233,959 (Direct) | View |
| 2019-05-15 Option Award | 2019-05-17 5:17 pm | N/A 2029-05-14 | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 67,500 | $0 | 67,500 (Direct) | View |